204 related articles for article (PubMed ID: 32946769)
1. Orthosteric and Allosteric Activation of Human 5-HT
Rodriguez Araujo N; Fabiani C; Mazzarini Dimarco A; Bouzat C; Corradi J
Biophys J; 2020 Oct; 119(8):1670-1682. PubMed ID: 32946769
[TBL] [Abstract][Full Text] [Related]
2. Unraveling mechanisms underlying partial agonism in 5-HT3A receptors.
Corradi J; Bouzat C
J Neurosci; 2014 Dec; 34(50):16865-76. PubMed ID: 25505338
[TBL] [Abstract][Full Text] [Related]
3. Conformational Changes in the 5-HT
Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
[TBL] [Abstract][Full Text] [Related]
4. Delineation of the functional properties and the mechanism of action of TMPPAA, an allosteric agonist and positive allosteric modulator of 5-HT3 receptors.
Gasiorek A; Trattnig SM; Ahring PK; Kristiansen U; Frølund B; Frederiksen K; Jensen AA
Biochem Pharmacol; 2016 Jun; 110-111():92-108. PubMed ID: 27086281
[TBL] [Abstract][Full Text] [Related]
5. Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT
Powell AD; Grafton G; Roberts A; Larkin S; O'Neill N; Palandri J; Otvos R; Cooper AJ; Ulens C; Barnes NM
Br J Pharmacol; 2016 Dec; 173(24):3467-3479. PubMed ID: 27677804
[TBL] [Abstract][Full Text] [Related]
6. Activation of human 5-hydroxytryptamine type 3 receptors via an allosteric transmembrane site.
Lansdell SJ; Sathyaprakash C; Doward A; Millar NS
Mol Pharmacol; 2015 Jan; 87(1):87-95. PubMed ID: 25338672
[TBL] [Abstract][Full Text] [Related]
7. Auto-inhibition at a ligand-gated ion channel: a cross-talk between orthosteric and allosteric sites.
Hu XQ
Br J Pharmacol; 2015 Jan; 172(1):93-105. PubMed ID: 25176133
[TBL] [Abstract][Full Text] [Related]
8. Single-channel kinetic analysis for activation and desensitization of homomeric 5-HT(3)A receptors.
Corradi J; Gumilar F; Bouzat C
Biophys J; 2009 Sep; 97(5):1335-45. PubMed ID: 19720021
[TBL] [Abstract][Full Text] [Related]
9. A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors.
Thompson AJ; Lummis SC
Br J Pharmacol; 2013 Sep; 170(2):391-402. PubMed ID: 23822584
[TBL] [Abstract][Full Text] [Related]
10. The L293 residue in transmembrane domain 2 of the 5-HT3A receptor is a molecular determinant of allosteric modulation by 5-hydroxyindole.
Hu XQ; Lovinger DM
Neuropharmacology; 2008 Jun; 54(8):1153-65. PubMed ID: 18436267
[TBL] [Abstract][Full Text] [Related]
11. Microsecond-timescale simulations suggest 5-HT-mediated preactivation of the 5-HT
Guros NB; Balijepalli A; Klauda JB
Proc Natl Acad Sci U S A; 2020 Jan; 117(1):405-414. PubMed ID: 31871207
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.
Kurzwelly D; Barann M; Kostanian A; Combrink S; Bönisch H; Göthert M; Brüss M
Pharmacogenetics; 2004 Mar; 14(3):165-72. PubMed ID: 15167704
[TBL] [Abstract][Full Text] [Related]
13. Arginine 222 in the pre-transmembrane domain 1 of 5-HT3A receptors links agonist binding to channel gating.
Hu XQ; Zhang L; Stewart RR; Weight FF
J Biol Chem; 2003 Nov; 278(47):46583-9. PubMed ID: 12970351
[TBL] [Abstract][Full Text] [Related]
14. The 4'lysine in the putative channel lining domain affects desensitization but not the single-channel conductance of recombinant homomeric 5-HT3A receptors.
Gunthorpe MJ; Peters JA; Gill CH; Lambert JJ; Lummis SC
J Physiol; 2000 Jan; 522 Pt 2(Pt 2):187-98. PubMed ID: 10639097
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of serotonin and dopamine on human 5-HT3A receptor kinetics: interpretation within an allosteric kinetic model.
Solt K; Ruesch D; Forman SA; Davies PA; Raines DE
J Neurosci; 2007 Nov; 27(48):13151-60. PubMed ID: 18045909
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a 5-HT
Price KL; Lummis SCR
ACS Chem Neurosci; 2018 Jun; 9(6):1409-1415. PubMed ID: 29508995
[TBL] [Abstract][Full Text] [Related]
17. Open probability of homomeric murine 5-HT3A serotonin receptors depends on subunit occupancy.
Mott DD; Erreger K; Banke TG; Traynelis SF
J Physiol; 2001 Sep; 535(Pt 2):427-43. PubMed ID: 11533135
[TBL] [Abstract][Full Text] [Related]
18. Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+.
Hu XQ; Lovinger DM
J Physiol; 2005 Oct; 568(Pt 2):381-96. PubMed ID: 16096341
[TBL] [Abstract][Full Text] [Related]
19. Subtle Differences among 5-HT
Price KL; Hirayama Y; Lummis SCR
ACS Chem Neurosci; 2017 May; 8(5):1085-1091. PubMed ID: 28367632
[TBL] [Abstract][Full Text] [Related]
20. The 5-HT3B subunit confers spontaneous channel opening and altered ligand properties of the 5-HT3 receptor.
Hu XQ; Peoples RW
J Biol Chem; 2008 Mar; 283(11):6826-31. PubMed ID: 18187416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
